Area of research
Hepatology · Oncology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Inflammatory Biomarkers in Disease Prognosis, Cancer Mechanisms and Therapy, and Ferroptosis and cancer prognosis.
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Comparative efficacy of interventional therapy with or without targeted immunotherapy in Child-Pugh B hepatocellular carcinoma patients: a single-center, retrospective study
Notch1 signaling pathway contributes to sorafenib resistance in hepatocellular carcinoma by modulating the cell cycle, mitochondrial function, and epithelial–mesenchymal transition
A model based on Immunogenic cell death-related genes can predict prognosis and drug sensitivity in patients with hepatocellular carcinoma
Immune checkpoint inhibitors combined with targeted agents for the first-line treatment of advanced unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
Molecular typing and mutational characterization of rectal neuroendocrine neoplasms
Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway.
PubMed 2023cited by 4position: middle
Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index
Effects of TACE combined with sorafenib on survival of patients with hepatocellular carcinoma based on ALBI grades and tumor load layers And Establishment of prognosis prediction model
Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway
Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs
<sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer
Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver
Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only
Importance of SALL4 in the development and prognosis of hepatocellular carcinoma